Routine compensation-related share issuance with no material financial impact. No trading action warranted. Monitor next quarterly results for any updates on employee incentive plan costs.
TAK drugs
TAK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 8 $16.75entry
- T+1 · 4mo ago −0.84%α −1.68% · $16.61
- T+5 · 4mo ago −2.15%α −3.01% · $16.39
- T+20 · 3mo ago −0.18%α −3.45% · $16.72
- T+60 · 7w ago +6.63%α +4.13% · $17.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Takeda completed the issuance of 16.88 million ordinary shares (including treasury shares) at 5,050 yen per share under its employee long-term incentive plan, with a slight reduction from the original plan due to forfeiture of rights. The company states the impact on full-year financials is immaterial. This is a routine administrative update with no material effect on the stock.
Key Facts
- Issued 16,877,109 ordinary shares (10,780,950 new shares + 6,096,159 treasury shares) at 5,050 yen per share
- Total value approximately 85.2 billion yen
- Partial forfeiture of rights reduced the number of shares from originally planned 16,989,076
- Company says immaterial impact on FY2027 financials
Financial Impact
Total value of shares issued and disposed is approximately 85.2 billion yen (about 16.88 million shares at 5,050 yen per share), but the company explicitly states the impact on full-year financials is immaterial
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001395064-26-000278 |
| Document: 0001395064-26-000278-index-headers.html | 0001395064-26-000278 |
| Document: 0001395064-26-000278-index.html | 0001395064-26-000278 |
| Document: 0001395064-26-000278.txt | 0001395064-26-000278 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers